$1.57
▼ -0.6% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
MetaVia Says Patients on Experimental Obesity Drug Reach Highest Target Doses in Phase 1 Trial
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
OTC Markets Life Sciences Investor Forum: MetaVia CEO HH Kim and CFO Marshall Woodworth with Zacks SCR's David Bautz
Overview
52-week range
$0.97
$19
3% of range
Avg surprise (last 3)
+17.2%
Avg reaction (last 2)
+0.9%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.79 | $-0.76 | -4.0% | -119.4% | -0.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.14 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.26 | $-0.32 | +18.8% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.36 | $-0.57 | +36.8% | — | +2.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.55 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.85 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.32 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.75 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.15 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.85 | -$2.86 | +70.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-3M | $-4M | $-4M | — | $-6M | $-10M |
| Net income | $-4M | — | $-3M | $-4M | $-4M | — | $-6M | $-10M |
| EPS (diluted) | $-0.79 | — | $-0.14 | $-0.26 | $-3.93 | — | $-0.55 | $-1.85 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $14M | $10M | $14M | $18M | $11M | $16M | $22M | $28M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M |
| Total assets | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $5M | $6M | $8M | $9M | $8M | $8M | $9M | $10M |
| Total equity | $9M | $5M | $6M | $10M | $4M | $8M | $13M | $19M |
Implied volatility — last 90 days
No IV snapshots yet for MTVA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.